Who owns ELOXX PHARMACEUTICALS INC?
- CUSIP Number: 29014r301
Tip: Access positions for across all investors
Analyze quarterly positions in Eloxx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eloxx Pharmaceuticals stock
Who bought or sold ELOXX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 400k | $5.6M | 100% | Jun 2026 |
|
| EcoR1 Capital | 400k | $5.6M | 100% | Jun 2026 |
|
| Standard Life Aberdeen | 400k | $5.6M | 100% | Jun 2026 |
|
| Samsara BioCapital | 400k | $5.6M | 100% | Jun 2026 |
|
| Siren | 400k | $5.6M | 100% | Jun 2026 |
|
| Stonepine Capital Management | 397k | $5.5M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 79k | $1.1M | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 11k | $147k | 100% | Jun 2026 |
|
| Seven Grand Managers | 10k | $139k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 718.00 | $10k | 100% | Jun 2026 |
|
| UBS Group | 637.00 | $8.8k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 126.00 | $1.7k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 98.00 | $1.0k | 100% | Jun 2026 |
|
| Pioneer Family Office | 96.00 | $1.3k | 100% | Jun 2026 |
|
| Altshuler Shaham | 25.00 | $347.000000 | 100% | Jun 2026 |
|
| Barclays | 12.00 | $167.000400 | 100% | Jun 2026 |
|
| Old Point Trust & Financial Services N A | 5.00 | $69.000000 | 100% | Jun 2026 |
|
| Activest Wealth Management | 4.00 | $56.000000 | 100% | Jun 2026 |
|
| SBI Securities | 2.00 | $28.000000 | 100% | Jun 2026 |
|
| Point Nemo Capital | 1.00 | $14.000000 | 100% | Jun 2026 |
|